Vanda Pharmaceuticals, Inc. (VNDA)
6.19
-0.02
(-0.32%)
USD |
NASDAQ |
May 22, 16:00
6.17
-0.02
(-0.32%)
After-Hours: 20:00
Vanda Pharmaceuticals EPS Diluted (Quarterly) : -0.8168 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AnaptysBio, Inc. | -1.843 |
| Amgen, Inc. | 3.344 |
| Gossamer Bio, Inc. | -0.1993 |
| BridgeBio Pharma, Inc. | -0.8422 |
| Geron Corp. | -0.0054 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.57M |
| Revenue (Quarterly) | 51.72M |
| Total Expenses (Quarterly) | 100.28M |
| Enterprise Value | 183.00M |
| Gross Profit Margin (Quarterly) | 90.05% |
| Profit Margin (Quarterly) | -93.91% |
| Earnings Yield | -65.42% |
| Normalized Earnings Yield | -65.42 |